Clinigen Group Debt 2025

Clinigen Group Aktienanalyse

What does Clinigen Group do?

The Clinigen Group PLC is a global pharmaceutical company specializing in the provision of rare disease and hard-to-treat disease treatments. The company was founded in 2010 with the aim of quickly and efficiently providing access to life-saving medicines for patients. However, the history of Clinigen Group goes back further. The company has its roots in Besse Medical, an American drug distributor. In 2004, Clinigen acquired Besse Medical, followed by six more distributors in the US and Europe in the following years. These acquisitions formed the foundation for the current business model. The Clinigen Group's business model is based on three pillars. The first pillar is the "Clinigen Specialty Pharmaceuticals" sector, where the company manufactures and distributes life-saving drugs for severely ill patients worldwide. The second pillar is the "Unlicensed Medicines" business, which allows patients access to unlicensed medicines that are urgently needed in specific cases. Clinigen works with pharmaceutical companies and regulatory authorities to provide these medicines within a certain framework. The third pillar is the "Clinical Trials Supply" department, which supports and streamlines clinical studies by providing medicines and services. Overall, Clinigen offers a variety of products and services, all aimed at securing access to life-saving medicines for patients. These include drugs for the treatment of cancer, infections, autoimmune diseases, neurological diseases, and rare diseases. In addition, Clinigen also offers specialized logistics and distribution services to ensure that medicines reach patients quickly and efficiently. Today, Clinigen Group is a global company headquartered in the UK with offices in North America, Europe, and Asia. The company employs over 1,000 people and works with a variety of pharmaceutical companies and regulatory authorities. An important focus is on the development of new treatment options and therapies for rare and hard-to-treat diseases. Overall, Clinigen Group has established itself as an important player in the pharmaceutical and healthcare industry. The company offers a unique business model and a wide range of products and services to secure access to life-saving medicines for patients worldwide. With its focus on innovation and collaboration with other companies and authorities, Clinigen is committed to ensuring that patients receive quick and efficient access to the medicines they need. Clinigen Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Clinigen Group's Debt Structure

Clinigen Group's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Clinigen Group's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Clinigen Group’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Clinigen Group’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Clinigen Group stock

What is the debt of Clinigen Group this year?

Clinigen Group has a debt level of 0 GBP this year.

What was the debt of Clinigen Group compared to the previous year?

The debt of Clinigen Group has increased by 0% compared to the previous year dropped.

What are the consequences of high debt for investors in Clinigen Group?

High debt can pose a risk for investors of Clinigen Group, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Clinigen Group?

Low debt means that Clinigen Group has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Clinigen Group affect the company?

An increase in debt of Clinigen Group can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Clinigen Group affect the company?

A reduction in debt of Clinigen Group can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Clinigen Group?

Some factors that can influence the debt of Clinigen Group include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Clinigen Group so important for investors?

The debts of Clinigen Group are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Clinigen Group take to change the debt?

To change the debt, Clinigen Group can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Clinigen Group pay?

Over the past 12 months, Clinigen Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Clinigen Group is expected to pay a dividend of 0.55 GBP.

What is the dividend yield of Clinigen Group?

The current dividend yield of Clinigen Group is .

When does Clinigen Group pay dividends?

Clinigen Group pays a quarterly dividend. This is distributed in the months of April, December, April, January.

How secure is the dividend of Clinigen Group?

Clinigen Group paid dividends every year for the past 5 years.

What is the dividend of Clinigen Group?

For the upcoming 12 months, dividends amounting to 0.55 GBP are expected. This corresponds to a dividend yield of 5.93 %.

In which sector is Clinigen Group located?

Clinigen Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Clinigen Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Clinigen Group from 1/4/2022 amounting to 0.055 GBP, you needed to have the stock in your portfolio before the ex-date on 12/2/2021.

When did Clinigen Group pay the last dividend?

The last dividend was paid out on 1/4/2022.

What was the dividend of Clinigen Group in the year 2024?

In the year 2024, Clinigen Group distributed 0.409 GBP as dividends.

In which currency does Clinigen Group pay out the dividend?

The dividends of Clinigen Group are distributed in GBP.